---
source_image: "deposition-transcript+legal-filing+court-document+affidavit__EFTA01381327_20260130_p001_i001.png"
source_pdf: "EFTA01381327.pdf"
method: pdf_text
words: 511
confidence: 1.00
extracted: 2026-02-13T16:49:29.154792
---

Form S-I 
Table of Contents 
UNDERWRITING 
The selling stockholders arc offering 
shares of common stock described in this prospectus through a number of undenvritcrs. 
J.P. Morgan Securities LLC, Citigroup Global Markets Inc., Barclays Capital Inc., Deutsche Bank Securities Inc. and Morgan Stanley & Co. LLC 
arc acting as joint book-running managers of the offering and J.P. Morgan Securities LLC and Citigroup Global Markets Inc. are acting as 
representatives of the underwriters. We and the selling stockholders have entered into an underwriting agreement with the underwriters. Subject to 
the terms and conditions of the underwriting agreement. the selling stockholders have agreed to sell to the underwriters, and each underwriter has 
severally agreed to purchase, at the public offering price less the underwriting discounts and commissions set forth on the cover page of this 
prospectus, the number of shares of common stock listed next to its name in the following table: 
Name 
J.F. Morgan Securities I.LC 
Citigroup Global Markets Inc. 
Barclays Capital Inc. 
Deutsche Bank Securities Inc. 
Morgan Stanley & Co. I.I.0 
Wells Fargo Securities, 1.1.0 
LOYAL3 Securities, Inc. 
Total 
Number of 
Shares 
The underwriters arc committed to purchase all the common shares offered by the selling stockholders if they purchase any shares. The 
underwriting agreement also provides that if an underwriter defaults, the purchase commitments of non-dcfaulting underwriters may also be 
increased or the offering may be terminated. 
The underwriters propose to offer the common shares being sold by the selling stockholders directly to the public at the initial public 
offering price set forth on the cover page of this prospectus and to certain dealers at that price less a concession not in excess of S 
per share. 
Any such dealers may resell shams to certain other brokers or dealers at a discount of up to $ 
per share from the initial public offering price. 
After the initial public offering of the shams, the offering price and other selling terms may be changed by the underwriters. 
We and the selling stockholders have agreed to indemnify the underwriters against certain liabilities, including liabilities under the 
Securities Act. 
Option to Purchase Additional Shares 
The underwriters have an option to buy up to 
additional shares of common stock from the selling stockholders to cover sales of 
shares by the underwriters which exceed the number of shares specified in the table above. The underwriters have 30 days from the date of this 
prospectus to exercise this over-allotment option. Any shares purchased by the underwriters will be allocated among the selling stockholders on a 
pro rata basis bawd on the number of shares such selling stockholder has agreed to sell pursuant to the over-allotment option. If any shares arc 
purchased with this over-allotment option. the underwriters will purchase shares in approximately the same proportion as shown in the table above. 
If any additional shams of common stock arc purchased, the underwriters will offer the additional shares on the same terms as those on which the 
shares arc being offered. 
129 
httplAvww.sec.gov/Arehivestedgar/datatl609989/000119312515218883/d734898dsl.htm17/20/2015 10:30:13 AM) 
CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) 
CONFIDENTIAL 
DB-SDNY-0080216 
SDNY GM_00226400 
EFTA01381327
